Chinese Journal of Dermatology ›› 2024, Vol. 57 ›› Issue (4): 338-342.doi: 10.35541/cjd.20230214
• Original Articles • Previous Articles Next Articles
Zhang Furong1, Ma Shujun1, Tao Sujiang1, Wang Ying1, Lu Min2
Received:
2023-04-18
Revised:
2023-12-12
Online:
2024-04-15
Published:
2024-04-07
Contact:
Wang Ying
E-mail:wangying88_2@hotmail.com
Zhang Furong, Ma Shujun, Tao Sujiang, Wang Ying, Lu Min. Clinical characteristics and drug resistance analysis of 8 cases of Kluyveromyces marxianus (Candida kefyr) infection[J]. Chinese Journal of Dermatology, 2024, 57(4): 338-342.doi:10.35541/cjd.20230214
[1] | 慎慧, 郭建, 张旻, 等. 上海地区临床分离念珠菌的耐药性监测[J]. 中国感染与化疗杂志, 2019,19(3):292⁃299. doi: 10. 16718/j.1009⁃7708.2019.03.013. |
[2] | Colombo AL, Júnior J, Guinea J. Emerging multidrug⁃resistant Candida species[J]. Curr Opin Infect Dis, 2017,30(6):528⁃538. doi: 10.1097/QCO.0000000000000411. |
[3] | Dufresne SF, Marr KA, Sydnor E, et al. Epidemiology of Candida kefyr in patients with hematologic malignancies[J]. J Clin Microbiol, 2014,52(6):1830⁃1837. doi: 10.1128/JCM.00131⁃14. |
[4] | Fekkar A, Meyer I, Brossas JY, et al. Rapid emergence of echinocandin resistance during Candida kefyr fungemia treatment with caspofungin[J]. Antimicrob Agents Chemother, 2013,57(5):2380⁃2382. doi: 10.1128/AAC.02037⁃12. |
[5] | Ahmad S, Khan Z, Al⁃Sweih N, et al. Candida auris in various hospitals across Kuwait and their susceptibility and molecular basis of resistance to antifungal drugs[J]. Mycoses, 2020,63(1):104⁃112. doi: 10.1111/myc.13022. |
[6] | Bretagne S, Renaudat C, Desnos⁃Ollivier M, et al. Predisposing factors and outcome of uncommon yeast species⁃related fungaemia based on an exhaustive surveillance programme (2002⁃14)[J]. J Antimicrob Chemother, 2017,72(6):1784⁃1793. doi: 10.1093/jac/dkx045. |
[7] | Clinical and Laboratory Standards Institute(CLSI). Performance standards for antifungal susceptibility testing of yeasts: CLSI M60[S]. Wayne, PA: CLSI, 2018. |
[8] | Clinical and Laboratory Standards Institute(CLSI). CLSI document M27⁃A3 reference method for broth dilution antifungal susceptibility testing of yeasts; approved standard⁃third edition[S]. Wayne, PA: CLSI, 2008. |
[9] | Clinical and Laboratory Standards Institute(CLSI). CLSI supplement M59 epidemiological cutoff values for antifungal susceptibility testing; 3rd ed[S]. Wayne, PA: CLSI,2020. |
[10] | Dufresne SF, Marr KA, Sydnor E, et al. Epidemiology of Candida kefyr in patients with hematologic malignancies[J]. J Clin Microbiol, 2014,52(6):1830⁃1837. doi: 10.1128/JCM.00131⁃ 14. |
[11] | Montravers P, Mira JP, Gangneux JP, et al. A multicentre study of antifungal strategies and outcome of Candida spp. peritonitis in intensive⁃care units[J]. Clin Microbiol Infect, 2011,17(7):1061⁃1067. doi: 10.1111/j.1469⁃0691.2010.03360.x. |
[12] | Aldejohann AM, Theuersbacher J, Haug L, et al. First case of Kluyveromyces marxianus (Candida kefyr) late onset keratitis after lamellar endothelial corneal graft[J]. Med Mycol Case Rep, 2021,32:21⁃24. doi: 10.1016/j.mmcr.2021.02.001. |
[13] | Lortholary O, Renaudat C, Sitbon K, et al. The risk and clinical outcome of candidemia depending on underlying malignancy[J]. Intensive Care Med, 2017,43(5):652⁃662. doi: 10.1007/s00134⁃017⁃4743⁃y. |
[14] | Ahmad S, Khan Z, Al⁃Sweih N, et al. Candida kefyr in Kuwait: prevalence, antifungal drug susceptibility and genotypic heterogeneity[J/OL]. PLoS One, 2020,15(10):e0240426. doi: 10.1371/journal.pone.0240426. |
[15] | Diba K, Makhdoomi K, Nasri E, et al. Emerging Candida species isolated from renal transplant recipients: species distribution and susceptibility profiles[J]. Microb Pathog, 2018,125:240⁃245. doi: 10.1016/j.micpath.2018.09.026. |
[16] | Weichert S, Reinshagen K, Zahn K, et al. Candidiasis caused by Candida kefyr in a neonate: case report[J]. BMC Infect Dis, 2012,12:61. doi: 10.1186/1471⁃2334⁃12⁃61. |
[17] | Kalkanci A, Saracli MA, Guzel O, et al. Clustering of nosocomial Candida kefyr infections among hematological patients in a university hospital: molecular typing of the strains by PFGE and RAPD[J]. J Mycol Med, 2007,17(4):250255. doi: 10.1016/j.mycmed.2007.09.003. |
[18] | Karabıçak N, Alem N. Antifungal susceptibility profiles of Candida species to triazole: application of new CLSI species⁃specific clinical breakpoints and epidemiological cutoff values for characterization of antifungal resistance[J]. Mikrobiyol Bul, 2016,50(1):122⁃132. doi: 10.5578/mb.10682. |
[19] | Pfaller MA, Diekema DJ, Turnidge JD, et al. Twenty years of the SENTRY Antifungal Surveillance Program: results for Candida species from 1997⁃2016[J]. Open Forum Infect Dis, 2019,6(Suppl 1):S79⁃S94. doi: 10.1093/ofid/ofy358. |
[20] | Khan Z, Ahmad S, Al⁃Obaid K, et al. Candida kefyr as a cause of bloodstream infection and adjunctive role of biomarkers in its diagnosis[J]. J Mycol Med, 2015,25(1):71⁃75. doi: 10.1016/j.mycmed.2014.04.002. |
[21] | Jung DS, Farmakiotis D, Jiang Y, et al. Uncommon Candida species fungemia among cancer patients, Houston, Texas, USA[J]. Emerg Infect Dis, 2015,21(11):1942⁃1950. doi: 10.3201/eid2111.150404. |
[22] | Colombo AL, Júnior J, Guinea J. Emerging multidrug⁃resistant Candida species[J]. Curr Opin Infect Dis, 2017,30(6):528⁃538. doi: 10.1097/QCO.0000000000000411. |
[23] | Seth⁃Smith H, Büchler AC, Hinic V, et al. Bloodstream infection with Candida kefyr/Kluyveromyces marxianus: case report and draft genome[J]. Clin Microbiol Infect, 2020,26(4):522⁃524. doi: 10.1016/j.cmi.2019.11.014. |
[24] | Staab JF, Neofytos D, Rhee P, et al. Target enzyme mutations confer differential echinocandin susceptibilities in Candida kefyr[J]. Antimicrob Agents Chemother, 2014,58(9):5421⁃5427. doi: 10.1128/AAC.00096⁃14. |
[25] | Çuhadar T, Kalkancı A. Emerging pathogen: Candida kefyr (Kluvyeromyces marxianus)[J]. Mikrobiyol Bul, 2017,51(4):387⁃395. doi: 10.5578/mb.61813. |
[26] | Wang E, Farmakiotis D, Yang D, et al. The ever⁃evolving landscape of candidaemia in patients with acute leukaemia: non⁃susceptibility to caspofungin and multidrug resistance are associated with increased mortality[J]. J Antimicrob Chemother, 2015,70(8):2362⁃2368. doi: 10.1093/jac/dkv087. |
[1] | Zhu Bangyong, Zhou Qian, Wei Jiangping, Gan Quan, Huang Yinjie, Yin Yueping, Xu Wenqi. Susceptibility of gonococcal clinical isolates to gentamicin in Guangxi region [J]. Chinese Journal of Dermatology, 2023, 56(8): 737-741. |
[2] | Yang Lu, Duan Zhimin, He Yanyan, Wang Jianing, Chen Qing, Chen Xu, Li Min, . A preliminary study on Candida albicans-induced pyroptosis of murine bone marrow-derived macrophages [J]. Chinese Journal of Dermatology, 2023, 56(4): 301-308. |
[3] | Zhang Ruijun, Su Xiaorui, Li Ting, He Xiao, Yang Yuanwen, Kang Yuying, . Analysis of pathogens of mucosal candidiasis and their resistance to drugs in a third-grade class-A hospital in Taiyuan, Shanxi [J]. Chinese Journal of Dermatology, 2023, 56(1): 56-58. |
[4] | Chen Yuping, Zheng Hailin, Zhang Zhifeng, Mei Huan, Liu Weida, Liu Musang. Retrospective analysis of 201 clinical isolates of Aspergillus fumigatus from a hospital in Nanjing: clinical characteristics of infected patients and azole resistance [J]. Chinese Journal of Dermatology, 2022, 55(4): 316-320. |
[5] | Sun Jianlin, Zhang Yang, Zhang Yupeng, Lyu Xinxiang, Wang Junrui. Drug resistance and virulence characteristics of of Staphylococcus aureus isolated from skin sites of suppurative infections in Inner Mongolia [J]. Chinese Journal of Dermatology, 2022, 55(3): 200-207. |
[6] | Yang Lu, Duan Zhimin, Li Min. Mechanisms underlying the resistance of Candida albicans to echinocandin antifungals [J]. Chinese Journal of Dermatology, 2022, 55(12): 1114-1117. |
[7] | Ding Tiantian, Cui Baohong, Mi Shuhong, Zhang Yang, Zheng Hailin, Shi Jihai, Liu Weida. Comparison of drug susceptibility of and drug resistance mutations in fluconazole-resistant Candida albicans strains from superficial and deep infections [J]. Chinese Journal of Dermatology, 2022, 55(10): 874-878. |
[8] | Kong Xue, Shi Dongmei, Liu Weida. Application of antifungal agents in special populations [J]. Chinese Journal of Dermatology, 2022, 55(1): 80-83. |
[9] | Yang Rui, Kong Qingtao, Xu Jie, Zhang Chen, Sang Hong. Screening of susceptibility genes and an immunological study in a patient with recurrent cervical lymphadenitis caused by Candida albicans [J]. Chinese Journal of Dermatology, 2022, 55(1): 50-54. |
[10] | Luo Hong, Pan Kaisu, Zhang Lian, Tan Yuan, Huang Ao, Cao Cunwei. Evaluation of in vitro antifungal activity of berberine against Talaromyces marneffei in yeast phase [J]. Chinese Journal of Dermatology, 2022, 55(1): 55-57. |
[11] | Lin Zehang, Duan Zhimin, Xu Song, Chen Xu, Li Min. Regulatory effect of Candida albicans hyphae on the key autophagy-related molecule microtubule-associated protein 1 light chain 3 in murine bone marrow-derived macrophages [J]. Chinese Journal of Dermatology, 2021, 54(3): 189-195. |
[12] | Wang Ruojun, Li Ruoyu. Adverse reactions to interleukin-17A and its receptor antagonists in the treatment of psoriasis [J]. Chinese Journal of Dermatology, 2021, 54(2): 170-173. |
[13] | . In vitro inhibitory effect of Fe3O4 nanozymes against Candida albicans [J]. Chinese Journal of Dermatology, 2020, 53(7): 554-556. |
[14] | Lyu Yan, Zhang Yanli, Zhang Zhanpeng, Zhao Yajing, Zhang Yishan, Li Shuixiu, Zhang Hong. ATP1 promotes Candida albicans to escape from macrophage killing through regulating oxidative stress [J]. Chinese Journal of Dermatology, 2020, 53(7): 519-524. |
[15] | Li Xiuxiu, Wu Nan, Wang Zaixing, Li Hui, Liu Shengxiu, Wang Hongyan, Gao Min, Wang Peiguang. Microbiological culture of skin lesion exudates and drug sensitivity test in 176 inpatients with pemphigus [J]. Chinese Journal of Dermatology, 2020, 53(10): 791-794. |
|